SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis
The presentation of viral antigens to T cells via the MHC molecules is a critical component of the host response to viral infection. Here the authors suggest SARS-CoV-2 possesses the immune evasion strategy against the MHC class I pathway by targeting key transcriptional regulators.
Guardado en:
Autores principales: | Ji-Seung Yoo, Michihito Sasaki, Steven X. Cho, Yusuke Kasuga, Baohui Zhu, Ryota Ouda, Yasuko Orba, Paul de Figueiredo, Hirofumi Sawa, Koichi S. Kobayashi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/985ec8dc38ab4bd98cffc38c5682e3e9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity
por: Michihito Sasaki, et al.
Publicado: (2021) -
MRC5 cells engineered to express ACE2 serve as a model system for the discovery of antivirals targeting SARS-CoV-2
por: Kentaro Uemura, et al.
Publicado: (2021) -
Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells
por: Yi-Hsin Liang, et al.
Publicado: (2021) -
Tagging single nucleotide polymorphisms in the IRF1 and IRF8 genes and tuberculosis susceptibility.
por: Shiping Ding, et al.
Publicado: (2012) -
Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2
por: Marumi Ohno, et al.
Publicado: (2021)